Skip to Main Content

Paper Details

<i>CYP2D6</i> phenotypes are associated with adverse outcomes related to opioid medications.
Pharmgenomics Pers Med
21
2017
CYP2D6, CYP2D6 gene, CYP2D6 phenotype, CYP2D6 phenotypes, codeine, hydrocodone, nausea, oxycodone, participants, patients, tramadol
Author NameAffiliation
Janet E Olson
Janet E OlsonCenter for Individualized Medicine.
V??ronique L Roger
V??ronique L Roger
V??ronique L RogerKern Center for the Science of Health Care Delivery, Mayo Clinic
V??ronique L Roger
V??ronique L RogerKern Center for the Science of Health Care Delivery, Mayo Clinic
V??ronique L Roger
John L BlackCenter for Individualized Medicine.
John L Black
Paul Y TakahashiMayo Clinic
Pedro J CaraballoMayo Clinic
Nicholas B Larson
Suzette J Bielinski
Suzette J BielinskiCenter for Individualized Medicine.
Suzette J Bielinski
Suzette J BielinskiCenter for Individualized Medicine.
  • 1 - 17

Datasets

Release 1.2